The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study

The Feasibility and Safety of Surgery in Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Study

Immune checkpoint inhibitors (ICI) are revolutionizing care for cancer patients. The list of malignancies for which the Food and Drug Administration is granting approval is rapidly increasing. Furthermore, there is a concomitant increase in clinical trials incorporating ICI. However, the safety of I...

Full description

Bibliographic Details
Main Authors: Alexandra W. Elias, Pashtoon M. Kasi, John A. Stauffer, David D. Thiel, Dorin T. Colibaseanu, Kabir Mody, Richard W. Joseph, Sanjay P. Bagaria
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-06-01
Series:Frontiers in Oncology
Subjects:
immune checkpoint inhibitors
surgery
morbidity
serious adverse events
cancer
Online Access:http://journal.frontiersin.org/article/10.3389/fonc.2017.00121/full

Internet

http://journal.frontiersin.org/article/10.3389/fonc.2017.00121/full

Similar Items